Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report20 March 2020
Urenco has ongoing detailed preparations in place to ensure the safety and wellbeing of our employees, communities and key stakeholders, and our ability to keep our plants operating.
Dedicated teams have been put in place to manage the risk. They are closely monitoring local conditions and government advice and they have prepared a comprehensive response plan.
All business travel to other countries has ceased. We are not running visitor tours of our sites and employees who can work from home are being required to do so.
Increased hygiene measures have been implemented at all sites. Guidance has been issued to managers and supervisors and employees are being updated daily on what actions they should be taking.
We are working closely with suppliers and business partners to mitigate any risks and are receiving regular updates from them. We have additional stock in place for critical components, which provides an extra degree of risk mitigation, and we have sourced alternative products where there are shortages of supply.
We are confident about our proactive preventative preparations and our resilience is further strengthened by our ability to provide services for our customers from our sites in mainland Europe, the UK and the USA.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries